Progress update on UK NSC’s recommendation to screen for tyrosinaemia
Oversight group gets to work in following up UK NSC’s recommendation for the implementation of newborn screening for Hereditary Tyrosinaemia Type 1.
Oversight group gets to work in following up UK NSC’s recommendation for the implementation of newborn screening for Hereditary Tyrosinaemia Type 1.
Details of changes to the national screening system from 1 October, due to the closure of Public Health England.
The NHS severe combined immunodeficiency (SCID) screening evaluation in England is scheduled to start from September 2021.
In 2016 the UK National Screening Committee (UK NSC) was piloting a new approach for reviewing existing screening programmes.
Professor Anne Mackie reflects on 2015 calling it 'a particularly exciting year for screening'.